B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CARM1

MOLECULAR TARGET

coactivator associated arginine methyltransferase 1

UniProt: Q86X55NCBI Gene: 104983 compounds

CARM1 (coactivator associated arginine methyltransferase 1) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CARM1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1molibresib3.8144
2sinefungin3.7441
3s adenosylhomocysteine1.102

About CARM1 as a Drug Target

CARM1 (coactivator associated arginine methyltransferase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented CARM1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CARM1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.